John Harrington
Keine laufenden Positionen mehr
Vermögen: 109 $ am 30.04.2024
Karriereverlauf von John Harrington
Ehemalige bekannte Positionen von John Harrington
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATHERSYS, INC. | Direktor/Vorstandsmitglied | 24.10.1995 | 16.06.2022 |
| Technik-/Wissenschafts-/F&E-Leiter | 24.10.1995 | 16.06.2022 | |
| Gründer | 24.10.1995 | 16.06.2022 | |
| BTHC VI, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | 06.09.2007 |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Direktor/Vorstandsmitglied | 08.06.2007 | 08.06.2007 |
| Technik-/Wissenschafts-/F&E-Leiter | 08.06.2007 | 08.06.2007 | |
| Gründer | 08.06.2007 | 08.06.2007 |
Ausbildung von John Harrington
| University of California San Diego | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| BTHC VI, Inc. | Finance |
Athersys, Inc. /Old/
Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Health Technology |
- Börse
- Insiders
- John Harrington
- Erfahrung